Humana Inc. (HUM)
286.13
-8.91 (-3.02%)
At close: Apr 14, 2025, 3:21 PM
-3.02% (1D)
| Bid | 285.94 |
| Market Cap | 34.53B |
| Revenue (ttm) | 117.76B |
| Net Income (ttm) | 1.21B |
| EPS (ttm) | 9.97 |
| PE Ratio (ttm) | 28.7 |
| Forward PE | 17.93 |
| Analyst | Hold |
| Ask | 286.37 |
| Volume | 1,000,786 |
| Avg. Volume (20D) | 1,700,944 |
| Open | 296.00 |
| Previous Close | 295.04 |
| Day's Range | 282.00 - 297.74 |
| 52-Week Range | 213.31 - 406.46 |
| Beta | 0.63 |
About HUM
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts...
Industry Medical - Healthcare Plans
Sector Healthcare
IPO Date Dec 31, 1981
Employees 65,680
Stock Exchange NYSE
Ticker Symbol HUM
Website https://www.humana.com
Analyst Forecast
According to 21 analyst ratings, the average rating for HUM stock is "Hold." The 12-month stock price forecast is $286.5, which is an increase of 0.13% from the latest price.
Stock ForecastsNext Earnings Release
Humana Inc. is scheduled to release its earnings on Apr 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+10.69%
Shares of health insurers are trading higher follo...
Unlock content with
Pro Subscription
5 days ago
+0.37%
Shares of health insurers are trading higher following a WSJ report indicating the Trump administration will increase payment rates for Medicare insurers.
